Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Clinical trial NCT00852709 · TERMINATED

Trial details

NCT number

NCT00852709

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2007-09-01

Primary completion

2009-11-20

Enrollment

35

View on ClinicalTrials.gov